Get started
Author

Petter Langlete

Observed names: Langlete, Petter, P. Langlete
ORCID: 0000-0002-2402-2541
Observed ORCID: 0000-0002-2402-2541
OpenAlex ID: A5086563529
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
2023 · Lamprini Veneti, Jacob Dag Berild, et al. · International Journal of Infectious Diseases · 33
Evaluation of the pilot wastewater surveillance for SARS-CoV-2 in Norway, June 2022 – March 2023
2023 · Ettore Amato, Susanne Hyllestad, et al. · BMC Public Health · 16
PDF
Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
2023 · Petter Langlete, Martin Tesli, et al. · Vaccine · 11
Healthcare-associated COVID-19 infections and mortality
2025 · P. Langlete, H.-M. Eriksen-Volle, et al. · Journal of Hospital Infection · 8
PDF
Effectiveness of environmental surveillance of SARS-CoV-2 as an early-warning system: Update of a systematic review during the second year of the pandemic
2023 · Jose Antonio Baz Lomba, João Pires, et al. · Journal of Water and Health · 6
PDF
Extreme weather and drinking water safety: impacts of the 2023 flood Hans in Norway
2025 · Anders Bekkelund, Petter Langlete, et al. · International Journal of Hygiene and Environmental Health · 2
Vaccine Effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTtech) Vaccine Against Reported SARS-CoV-2 Delta and Omicron Infection Among Adolescents, Norway, August 2021 to January 2022
2022 · Lamprini Veneti, Jacob Dag Berild, et al. · SSRN Electronic Journal · 2
Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators
2025 · Gunnar Rø, Trude Marie Lyngstad, et al. · PLoS ONE · 1
Works count: 13
Citation count: 79
H-index: 5
I10-index: 3
Year
Topic
Type